PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Vaccination coverage and associated factors for receipt of the 23-valent pneumococcal polysaccharide vaccine in Taiwan: A nation-wide community-based study.

Abstract Older adults, particularly those with chronic obstructive pulmonary disease, are advised to receive 23-valent pneumococcal polysaccharide vaccine (PPV23). However, the PPV23 vaccination rate in Taiwan and the determinants of receipt remain unclear.We analyzed the data of 1475 community-dwelling older adults aged ≥75 years who participated in the Healthy Aging Longitudinal Study in Taiwan. Each participant received assessments of PPV23 status, sociodemographic factors (age, sex, education level, marital status, living alone, and occupation), and health-related factors (chronic diseases, smoking status, alcohol intake, physical activities, cognitive status, and physical performance). PPV23 rate was defined as the number of participants who reported receiving free PPV23 divided by the total number of candidates for free PPV23. Multinomial logistic regression analysis was applied to investigate the sociodemographic and health-related determinants of PPV23 status.A PPV23 vaccination rate of 20.7% (305/1475) was observed. Participants who were female, current smokers, and had a low peak expiratory flow were associated with PPV23 nonreceipt (all P <.05). Of the participants who had a low peak expiratory flow, low education status, and physical inactivity were associated with PPV23 nonreceipt (all P <.05).The PPV23 vaccination rate among adults aged ≥75 years was low. Older adults who were women, current smokers, or who had a low PEF were less likely to receive the PPV23. These findings support continual efforts to improve the PPV23 coverage rate in vulnerable populations.
PMID
Related Publications

Cost-effectiveness of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK.

Invasive pneumococcal disease, comorbidities, and polysaccharide vaccine use in children aged 5-15 years in England and Wales.

Effectiveness of 23-valent pneumococcal polysaccharide vaccine on diabetic elderly.

Recommendations for prevention of community-acquired pneumonia with bacteremia as the leading form of invasive pneumococcal infections in the population of people over 50 years of age and risk groups above 19 years of age.

Determinants of influenza vaccination in older adults: A nationwide community-based study in Taiwan.

Authors

Mayor MeshTerms

Pneumococcal Vaccines

Keywords
Journal Title medicine
Publication Year Start




PMID- 29384869
OWN - NLM
STAT- MEDLINE
DCOM- 20180209
LR  - 20180221
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Linking)
VI  - 97
IP  - 5
DP  - 2018 Feb
TI  - Vaccination coverage and associated factors for receipt of the 23-valent
      pneumococcal polysaccharide vaccine in Taiwan: A nation-wide community-based
      study.
PG  - e9773
LID - 10.1097/MD.0000000000009773 [doi]
AB  - Older adults, particularly those with chronic obstructive pulmonary disease, are 
      advised to receive 23-valent pneumococcal polysaccharide vaccine (PPV23).
      However, the PPV23 vaccination rate in Taiwan and the determinants of receipt
      remain unclear.We analyzed the data of 1475 community-dwelling older adults aged 
      &gt;/=75 years who participated in the Healthy Aging Longitudinal Study in Taiwan.
      Each participant received assessments of PPV23 status, sociodemographic factors
      (age, sex, education level, marital status, living alone, and occupation), and
      health-related factors (chronic diseases, smoking status, alcohol intake,
      physical activities, cognitive status, and physical performance). PPV23 rate was 
      defined as the number of participants who reported receiving free PPV23 divided
      by the total number of candidates for free PPV23. Multinomial logistic regression
      analysis was applied to investigate the sociodemographic and health-related
      determinants of PPV23 status.A PPV23 vaccination rate of 20.7% (305/1475) was
      observed. Participants who were female, current smokers, and had a low peak
      expiratory flow were associated with PPV23 nonreceipt (all P &lt;.05). Of the
      participants who had a low peak expiratory flow, low education status, and
      physical inactivity were associated with PPV23 nonreceipt (all P &lt;.05).The PPV23 
      vaccination rate among adults aged &gt;/=75 years was low. Older adults who were
      women, current smokers, or who had a low PEF were less likely to receive the
      PPV23. These findings support continual efforts to improve the PPV23 coverage
      rate in vulnerable populations.
FAU - Chen, Chang-Hua
AU  - Chen CH
AD  - Division of Infectious Diseases, Department of Internal Medicine.
AD  - Center for Aging and Health, Changhua Christian Hospital, Changhua City.
FAU - Wu, Ming-Shiang
AU  - Wu MS
AD  - Institute of Population Health Sciences, National Health Research Institutes,
      Zhunan, Miaoli County, Taiwan.
FAU - Wu, I-Chien
AU  - Wu IC
AD  - Institute of Population Health Sciences, National Health Research Institutes,
      Zhunan, Miaoli County, Taiwan.
LA  - eng
PT  - Journal Article
PT  - Observational Study
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
RN  - 0 (23-valent pneumococcal capsular polysaccharide vaccine)
RN  - 0 (Pneumococcal Vaccines)
SB  - AIM
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - Female
MH  - Health Policy
MH  - Health Status
MH  - Humans
MH  - Independent Living
MH  - Logistic Models
MH  - Longitudinal Studies
MH  - Male
MH  - Pneumococcal Infections/*prevention &amp; control
MH  - *Pneumococcal Vaccines
MH  - Socioeconomic Factors
MH  - Taiwan
MH  - Vaccination Coverage/*statistics &amp; numerical data
PMC - PMC5805441
EDAT- 2018/02/01 06:00
MHDA- 2018/02/10 06:00
CRDT- 2018/02/01 06:00
PHST- 2018/02/01 06:00 [entrez]
PHST- 2018/02/01 06:00 [pubmed]
PHST- 2018/02/10 06:00 [medline]
AID - 10.1097/MD.0000000000009773 [doi]
AID - 00005792-201802020-00031 [pii]
PST - ppublish
SO  - Medicine (Baltimore). 2018 Feb;97(5):e9773. doi: 10.1097/MD.0000000000009773.